• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.44%

    Synageva BioPharma Corp. (GEVA)

    -NasdaqGS
    103.92 Down 4.59(4.23%) 12:54PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:108.51
    Open:108.83
    Bid:104.33 x 100
    Ask:105.12 x 100
    1y Target Est:114.25
    Beta:0.12
    Earnings Date:Apr 28 - May 4 (Est.)
    Day's Range:103.83 - 110.83
    52wk Range:60.19 - 122.88
    Volume:268,265
    Avg Vol (3m):302,614
    Market Cap:3.84B
    P/E (ttm):N/A
    EPS (ttm):-5.89
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GEVA

    Comparison

    Symbol% ChgMkt Cap
    GEVADown 4.23%3.84B
    GILDDown 0.91%152.38B
    MRKDown 0.30%162.44B
    PFEDown 0.93%214.55B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):617.73
    Ex-Dividend Date:30-Dec-08

    Analysts

    Annual EPS Est (Dec-15) :-7.49
    Quarterly EPS Est (Mar-15) :-1.70
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synageva BioPharma Corp. operates as a biopharmaceutical company in the United States. It focuses on the discovery, development, and commercialization of therapeutic products for patients with rare diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback